http://www.rxpgnews.com/ Medical News and Information Thu, 21 Aug 2008 02:00:28 PST en-us http://www.rxpgnews.com/lucinactant/Surfaxin_Lucinactant_Granted_Orphan_Drug_Designati_2744_2744.shtml Lucinactant Discovery Laboratories, Inc. (Nasdaq: DSCO), today announced that the Office of Orphan Products Development of the United States Food and Drug Administration has granted orphan drug designation to Discovery's lead product, Surfaxin(r), for the treatment of Bronchopulmonary Dysplasia (also known as Chronic Lung Disease, CLD) in premature infants. Sat, 29 Oct 2005 16:49:00 PST http://www.rxpgnews.com/lucinactant/Surfaxin_Lucinactant_Granted_Orphan_Drug_Designati_2744_2744.shtml